Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2017, Article ID 8132672, 10 pages
https://doi.org/10.1155/2017/8132672
Research Article

Analysis of Risk Factors for Kidney Retransplant Outcomes Associated with Common Induction Regimens: A Study of over Twelve-Thousand Cases in the United States

Department of Medicine, Division of Nephrology, Hypertension and Renal Transplantation, University of Florida, Gainesville, FL, USA

Correspondence should be addressed to Alfonso H. Santos Jr.; ude.lfu.enicidem@sotnas.osnofla

Received 22 May 2017; Accepted 24 July 2017; Published 24 September 2017

Academic Editor: John Paul Scott

Copyright © 2017 Alfonso H. Santos Jr. et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, and Urologic Division of Kidney, “US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States,” American Journal of Kidney Diseases, vol. 67, no. 3, p. A4, 2016. View at Publisher · View at Google Scholar
  2. P. S. Rao, D. E. Schaubel, G. Wei, and S. S. A. Fenton, “Evaluating the survival benefit of kidney retransplantation,” Transplantation, vol. 82, no. 5, pp. 669–674, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. D. Miles, D. E. Schaubel, X. Jia, A. O. Ojo, F. K. Port, and P. S. Rao, “Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys,” The American Journal of Transplantation, vol. 7, no. 5, pp. 1140–1147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Marcén and J. L. Teruel, “Patient outcomes after kidney allograft loss,” Transplantation Reviews, vol. 22, no. 1, pp. 62–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. O. Ojo, R. A. Wolfe, L. Y. Agoda et al., “Prognosis after primary renal, transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States renal data system,” Transplantation, vol. 66, no. 12, pp. 1651–1659, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Gruber, K. L. Brown, J. M. El-Amm et al., “Equivalent outcomes with primary and retransplantation in African-American deceased-donor renal allograft recipients,” Surgery, vol. 146, no. 4, pp. 646–653, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Pour-Reza-Gholi, M. Nafar, A. Saeedinia et al., “Kidney retransplantation in comparison with first kidney transplantation,” Transplantation Proceedings, vol. 37, no. 7, pp. 2962–2964, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. S. Rao and A. Ojo, “Organ retransplantation in the United States: trends and implications,” Clinical Transplants, pp. 57–67, 2008. View at Google Scholar · View at Scopus
  9. R. D. Morgan, J. M. O'Callaghan, S. R. Knight, and P. J. Morris, “Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis,” Transplantation, vol. 93, no. 12, pp. 1179–1188, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. T. M. Chapman and G. M. Keating, “Basiliximab: a review of its use as induction therapy in renal transplantation,” Drugs, vol. 63, no. 24, pp. 2803–2835, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Sollinger, B. Kaplan, M. D. Pescovitz et al., “Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection,” Transplantation, vol. 72, no. 12, pp. 1915–1919, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Haririan, K. Morawski, D. H. Sillix et al., “Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients,” Transplantation, vol. 79, no. 6, pp. 716–721, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. E. D. Deeks and G. M. Keating, “Rabbit Antithymocyte Globulin (Thymoglobulin®): A review of its use in the prevention and treatment of acute renal allograft rejection,” Drugs, vol. 69, no. 11, pp. 1483–1512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Knight, R. H. Kerman, L. Schoenberg et al., “The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function,” Transplantation, vol. 78, no. 6, pp. 904–910, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Hanaway, E. S. Woodle, S. Mulgaonkar et al., “Alemtuzumab induction in renal transplantation,” The New England Journal of Medicine, vol. 364, no. 20, pp. 1909–1919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. K. L. Hardinger, D. C. Brennan, and C. L. Klein, “Selection of induction therapy in kidney transplantation,” Transplant International, vol. 26, no. 7, pp. 662–672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. P.-T. Pham, M. Everly, A. Faravardeh, and P.-C. Pham, “Management of patients with a failed kidney transplant: dialysis reinitiation, immunosuppression weaning, and transplantectomy,” World Journal of Nephrology, vol. 4, no. 2, pp. 148–159, 2015. View at Publisher · View at Google Scholar
  18. J. Schold, E. Poggio, D. Goldfarb, L. Kayler, and S. Flechner, “Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States,” Transplantation, vol. 99, no. 6, pp. 1165–1171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Perl, J. M. Bargman, S. J. Davies, and S. V. Jassal, “Clinical outcomes after failed renal transplantation - Does dialysis modality matter?” Seminars in Dialysis, vol. 21, no. 3, pp. 239–244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. P. S. Rao, D. E. Schaubel, and R. Saran, “Impact of graft failure on patient survival on dialysis: A comparison of transplant-naïve and post-graft failure mortality rates,” Nephrology Dialysis Transplantation, vol. 20, no. 2, pp. 387–391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Marcén, J. Pascual, A. M. Tato et al., “Renal transplant recipient outcome after losing the first graft,” Transplantation Proceedings, vol. 35, no. 5, pp. 1679–1681, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. S. Abouljoud, M. H. Deierhoi, S. L. Hudson, and A. G. Diethelm, “Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy,” Transplantation, vol. 60, no. 2, pp. 138–144, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. E. L. G. Heaphy, E. D. Poggio, S. M. Flechner et al., “Risk factors for retransplant kidney recipients: Relisting and outcomes from patients' primary transplant,” American Journal of Transplantation, vol. 14, no. 6, pp. 1356–1367, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Kousoulas, F. W. Vondran, P. Syryca, J. Klempnauer, H. Schrem, and F. Lehner, “Risk-Adjusted Analysis of Relevant Outcome Drivers for Patients after More Than Two Kidney Transplants,” Journal of Transplantation, vol. 2015, Article ID 712049, 9 pages, 2015. View at Publisher · View at Google Scholar
  25. P. S. Rao, D. E. Schaubel, X. Jia, S. Li, F. K. Port, and R. Saran, “Survival on Dialysis Post-Kidney Transplant Failure: Results From the Scientific Registry of Transplant Recipients,” American Journal of Kidney Diseases, vol. 49, no. 2, pp. 294–300, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Lair, S. Coupel, M. Giral et al., “The effect of a first kidney transplant on a subsequent transplant outcome: An Experimental and Clinical Study,” Kidney International, vol. 67, no. 6, pp. 2368–2375, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. G. P. Bayliss, R. Y. Gohh, P. E. Morrissey, J. R. Rodrigue, and D. A. Mandelbrot, “Immunosuppression after renal allograft failure: A survey of US practices,” Clinical Transplantation, vol. 27, no. 6, pp. 895–900, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Leppke, T. Leighton, D. Zaun et al., “Scientific Registry of Transplant Recipients: Collecting, analyzing, and reporting data on transplantation in the United States,” Transplantation Reviews, vol. 27, no. 2, pp. 50–56, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. Matas, J. M. Smith, M. A. Skeans et al., “OPTN/SRTR 2012 Annual Data Report: Kidney,” American Journal of Transplantation, vol. 14, no. 1, pp. 11–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. T. P. Singh, C. S. Almond, G. Piercey, and K. Gauvreau, “Trends in wait-list mortality in children listed for heart transplantation in the United States: Era effect across racial/ethnic groups,” American Journal of Transplantation, vol. 11, no. 12, pp. 2692–2699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. J. P. Klein, J. D. Rizzo, M.-J. Zhang, and N. Keiding, “Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling,” Bone Marrow Transplantation, vol. 28, no. 11, pp. 1001–1011, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. 2004 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003, Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, Md, USA; United Network for Organ Sharing, Richmond, Va, USA; University Renal Research and Education Association, Ann Arbor, Mich, USA, 2004, https://optn.transplant.hrsa.gov/data/citing-data/Accessed1/5/2017.
  33. “Erratum Regarding “US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States” (Am J Kidney Dis. 2015;66[1][suppl 1]:S1-S305),” American Journal of Kidney Diseases, vol. 66, no. 3, p. 545, 2015. View at Publisher · View at Google Scholar
  34. R. Marcén, A. Fernández, M. F. Lucas, J. L. Teruel, I. Pérez-Flores, and A. Sánchez-Fructuoso, “Retransplant,” Nefrologia, vol. 29, no. 1, pp. 63–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Opelz and B. Döhler, “Association of HLA mismatch with death with a functioning graft after kidney transplantation: A collaborative transplant study report,” American Journal of Transplantation, vol. 12, no. 11, pp. 3031–3038, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Opelz and B. Döhler, “Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation,” Transplantation, vol. 89, no. 5, pp. 567–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. Alemtuzumab, http://www.drugs.com/monograph/alemtuzumab.html.
  38. J. Pascual, J. D. Mezrich, A. Djamali et al., “Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation,” Transplantation, vol. 83, no. 11, pp. 1429–1434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. J. N. An, J. P. Lee, Y. J. Oh et al., “Incidence of post-transplant glomerulonephritis and its impact on graft outcome,” Kidney Research and Clinical Practice, vol. 31, no. 4, pp. 219–226, 2012. View at Publisher · View at Google Scholar
  40. J. D. Pirsch, R. J. Ploeg, S. Gange et al., “Determinants of graft survival after renal transplantation,” Transplantation, vol. 61, no. 11, pp. 1581–1586, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. 3C Study Collaborative Group, R. Haynes, and P. Harden, “Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial,” The Lancet, vol. 384, no. 9955, pp. 1684–1690, 2014. View at Publisher · View at Google Scholar
  42. O. K. Serrano, P. Friedmann, S. Ahsanuddin, C. Millan, A. Ben-Yaacov, and L. K. Kayler, “Outcomes associated with steroid avoidance and alemtuzumab among kidney transplant recipients,” Clinical Journal of the American Society of Nephrology, vol. 10, no. 11, pp. 2030–2038, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. S. M. Hussain, K. K. Sureshkumar, T. Y. Ko, and R. J. Marcus, “Effect of induction agent on posttransplant outcomes in deceased donor kidney transplant recipients: Influence of race,” Transplantation Proceedings, vol. 45, no. 1, pp. 119–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. A. A. Smith, M. M. John, I. S. Dortonne et al., “Racial Disparity in Renal Transplantation: Alemtuzumab the Great Equalizer?” Annals of Surgery, vol. 262, no. 4, pp. 699–674, 2015. View at Publisher · View at Google Scholar
  45. B. Kaplan, J. Schold, and H.-U. Meier-Kriesche, “Overview of large database analysis in renal transplantation,” American Journal of Transplantation, vol. 3, no. 9, pp. 1052–1056, 2003. View at Publisher · View at Google Scholar · View at Scopus